13-26337623-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001260.3(CDK8):c.185C>T(p.Ser62Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,288,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000031 ( 0 hom. )
Consequence
CDK8
NM_001260.3 missense
NM_001260.3 missense
Scores
11
5
3
Clinical Significance
Conservation
PhyloP100: 7.46
Genes affected
CDK8 (HGNC:1779): (cyclin dependent kinase 8) This gene encodes a member of the cyclin-dependent protein kinase (CDK) family. CDK family members are known to be important regulators of cell cycle progression. This kinase and its regulatory subunit, cyclin C, are components of the Mediator transcriptional regulatory complex, involved in both transcriptional activation and repression by phosphorylation of the carboxy-terminal domain of the largest subunit of RNA polymerase II. This kinase regulates transcription by targeting the cyclin-dependent kinase 7 subunits of the general transcription initiation factor IIH, thus providing a link between the Mediator complex and the basal transcription machinery. Multiple pseudogenes of this gene have been identified. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.93
PP5
Variant 13-26337623-C-T is Pathogenic according to our data. Variant chr13-26337623-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 805981.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-26337623-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDK8 | NM_001260.3 | c.185C>T | p.Ser62Leu | missense_variant | 2/13 | ENST00000381527.8 | NP_001251.1 | |
CDK8 | NM_001318368.2 | c.185C>T | p.Ser62Leu | missense_variant | 2/13 | NP_001305297.1 | ||
CDK8 | XM_047430033.1 | c.5C>T | p.Ser2Leu | missense_variant | 3/14 | XP_047285989.1 | ||
CDK8 | NM_001346501.2 | c.-277C>T | 5_prime_UTR_variant | 2/12 | NP_001333430.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK8 | ENST00000381527.8 | c.185C>T | p.Ser62Leu | missense_variant | 2/13 | 1 | NM_001260.3 | ENSP00000370938 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000310 AC: 4AN: 1288948Hom.: 0 Cov.: 24 AF XY: 0.00000157 AC XY: 1AN XY: 637218
GnomAD4 exome
AF:
AC:
4
AN:
1288948
Hom.:
Cov.:
24
AF XY:
AC XY:
1
AN XY:
637218
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Intellectual developmental disorder with hypotonia and behavioral abnormalities Pathogenic:3Other:1
not provided, no classification provided | phenotyping only | GenomeConnect, ClinGen | - | Variant interpreted as Pathogenic and reported on 03-18-2021 by Lab or GTR ID 239772. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München | Mar 26, 2020 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 11, 2023 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Jul 29, 2020 | - - |
Complex neurodevelopmental disorder with or without congenital anomalies Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Jun 06, 2023 | This sequence change in CDK8 is predicted to replace serine with leucine at codon 62, p.(Ser62Leu). The serine residue is highly conserved (97/97 vertebrates, UCSC), and is located in the protein kinase domain. There is a large physicochemical difference between serine and leucine. CDK8, in which the variant was identified, is a gene that has a low rate of benign missense variation and where pathogenic missense variants are a common mechanism of disease (gnomAD v2.1 missense constraint). This variant is absent from the population database gnomAD v2.1 and v3.1. This variant has been identified as a de novo occurrence with confirmed parental relationships in four individuals, as a de novo occurrence with unconfirmed parental relationships in five individuals, and expected de novo with unknown inheritance in two individuals, all with a syndromic neurodevelopmental disorder (PMID: 30905399, 33958710; DECIPHER patient: 293709, 409614; ClinVar: SCV001430065.1, SCV001439334.1, SCV002075047.1). Phosphorylation assays in a mammalian cell line showed reduced STAT1 phosphorylation indicating that this variant impacts protein function (PMID: 30905399). Computational evidence predicts a deleterious effect for the missense substitution (REVEL = 0.644). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as PATHOGENIC. Following criteria are met: PS2/PM6_VeryStrong, PS3_Supporting, PS4_Supporting, PM2_Supporting, PP2, PP3. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Uncertain
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MutPred
Loss of disorder (P = 0.0755);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at